CardiologyRounds.com
A Professional & Personal Networking Site for Cardiologists Worldwide
Dr. Afzal has not received any gifts yet
Give Dr. Afzal a Gift
Added by Dr. Afzal
Join CardiologyRounds.com
Welcome toCardiologyRounds.com
Sign Up or Sign In
Matthew Moore Give a Gift
Get Badge
ORIGINAL ARTICLE: Adverse Events Associated with Testosterone Administration
CORRESPONDENCE: 24-Hour Ambulatory Blood Pressure in the ACCOMPLISH Trial
EDITORIAL: Carotid-Artery Stenting in Stroke Prevention
ORIGINAL ARTICLE: Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
ORIGINAL ARTICLE: Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
PERSPECTIVE: Coronary Heart Disease and Prevention in the United States
CORRESPONDENCE: Food Reformulations to Reduce Trans Fatty Acids
EDITORIAL: Hypoplastic Left Heart Syndrome
ORIGINAL ARTICLE: Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions
EDITORIAL: Fear of Rejection â Monitoring the Heart-Transplant Recipient
Transradial PCI approach reduces bleeding, MACE in STEMI patients
COR-I: Combo drug leads to significant weight loss, but CV effects questioned
Sanofi-Aventis sues FDA over generic Lovenox approval
Advisory panel votes to recommend FDA approval of ticagrelor
Two new randomized trials bolster benefits of compression-only CPR
Traditional tools for gauging neurological prognosis post-cardiac arrest may no longer be accurate: Study
Taking patients directly to existing PCI centers is more cost-effective than expanding PCI capacity
Dr Terry Ferguson moves on to AstraZeneca
Arguments continue over the metabolic syndrome
Avoiding lowest-volume centers and adhering to quality measures lower cost of CABG overall
Inside This Issue
Clinical Characteristics of Patients Undergoing Surgical Ventricular Reconstruction by Choice and by Randomization
Evaluating Clinical Applicability: The STICH Trial's Findings
Snakelike Aortic Right Ventricular Tunnel With Anomalous Origin of Left Main Coronary Artery in an Adult Woman
The 9p21 Locus and Coronary Heart Disease: Initiator, Promoter, or Precipitator?
Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention: Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
Gene Dosage of the Common Variant 9p21 Predicts Severity of Coronary Artery Disease
The Glycoprotein IIb/IIIa Inhibitor Wars: An Update
STICH (Surgical Treatment for Ischemic Heart Failure) Trial Enrollment
Minimally-Invasive Implantation of Living Tissue Engineered Heart Valves: A Comprehensive Approach From Autologous Vascular Cells to Stem Cells
© 2010 Cardiology Rounds
Contact US | Report an Issue | Terms of Service
Please check your browser settings or contact your system administrator.
Comment Wall
You need to be a member of CardiologyRounds.com to add comments!
Join CardiologyRounds.com